Guardian Wealth Advisors (North Carolina)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Guardian Wealth Advisors (North Carolina)'s ABBV Position: Q2 2026 in Review
Guardian Wealth Advisors (North Carolina) increased its AbbVie (ABBV) stake by 0.36% in Q2 2026, buying an estimated $9.25K and bringing the position to 11,906 shares worth $3M. The position accounts for 0.17% of the portfolio, ranked #88.
Guardian Wealth Advisors (North Carolina) first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Guardian Wealth Advisors (North Carolina) held 11,906 shares of AbbVie worth $3M as of Q2 2026.
- Guardian Wealth Advisors (North Carolina) bought 43 AbbVie shares in Q2 2026, an estimated $9.25K.
- AbbVie made up 0.17% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q2 2026, its #88 holding.
- Guardian Wealth Advisors (North Carolina) first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q2 2026, filed 14 Aug 2026.